Latest news with #TDB
New Indian Express
4 days ago
- General
- New Indian Express
TDB to take over unniyappam production at Kottarakkara Mahaganapathy temple
KOLLAM: The Travancore Devaswom Board (TDB) will directly take over the production of Unniyappam at the Kottarakkara Mahaganapathy Temple. The decision was taken at a meeting of Deputy Devaswom Commissioners convened by the board on May 21. A subsequent board meeting issued an order that included the procurement of an Unniyappam-making kit. The move comes in the wake of a report by the board's vigilance wing, which found irregularities in the preparation and distribution of the Unniyappam. The board clarified that media reports claiming the cancellation of the decision to take over production are incorrect. TDB officials stated that the aim is to ensure quality offerings for devotees. A similar measure was adopted during the previous Sabarimala pilgrimage season, when the board directly handled the production of Appam and Aravana at Nilakkal, Erumeli, and Pandalam Devaswom.
New Indian Express
6 days ago
- Business
- New Indian Express
Kerala's Ambalappuzha palpayasam to cost more
ALAPPUZHA: Come August, the legendary Ambalappuzha palpayasam will cost more. The Travancore Devaswom Board (TDB) has decided to increase the price of the prasadam (consecrated food offering) served to devotees at the Ambalappuzha Sree Krishna Swamy temple to Rs 260 per litre from Rs 160. The quantity of palpayasam prepared will also be increased. Currently, 225 litres are prepared every day, which will be increased to 350 litres on Thursdays, Sundays and other auspicious days, and 300 litres on other days. Officials said the price of the palpayasam is being increased after 14 years. According to V J Sreekumar, koima sthani of the temple, the revision was decided by the TDB. 'Demand for the payasam has increased. However, production is controlled based on the direction of the Kerala High Court, to maintain sanctity,' he added. The palpayasam is distributed to devotees in adherence to norms prepared by the TDB and the HC. Of the 225 litres that is prepared daily, 70 litres is distributed to devotees who pre-book orders in one litre containers. Another 70 litres of the prasadam is offered daily on spot-booking basis in the same quantity. This is distributed at 11am every day after poojas. A further 60 litres is offered to devotees, half a litre each. The rest is used for temple rituals. One litre of the palpayasam is the most that a devotee can purchase, officials said. The TDB plans to introduce an online booking system for distribution of the prasadam. A directive has been issued to the devaswom deputy commissioner to introduce a mobile application for the purpose. Ninety litres will be made available for online booking after introduction of the app, officials said. The board has also initiated steps to make a larger varpu (bronze) vessel. A nearly 1,200-litre vessel will be required to prepare 350 litres of payasam. We will issue a tender for building the vessel, they said.
Bloomberg
02-06-2025
- Business
- Bloomberg
TDB Warns Losses on African Development Banks Set Dangerous Precedent
Forcing African development lenders to take losses in sovereign debt restructurings would set a dangerous precedent and increase the cost of financing on the continent, TDB Managing Director Admassu Tadesse cautioned. Zambia plans to impose losses on institutions including the Eastern and Southern African Trade and Development Bank, or TDB, and the African Export-Import Bank as it reworks $13.4 billion in loans spanning Chinese state-owned banks to bondholders. Finance Minister Situmbeko Musokotwane said last week the southern African nation must honor its agreement with other creditors, which includes subjecting TDB and Afreximbank loans to comparable treatment. Ghana has echoed this.
&w=3840&q=100)
Business Standard
30-05-2025
- Health
- Business Standard
Centre to aid development of indigenous thrombectomy device for stroke
Technology Development Board to fund S3V Vascular Technologies for manufacturing India's first thrombectomy device, aiming to reduce import dependency and boost stroke care Sanket Koul New Delhi In a push for India's medtech innovation landscape, the Technology Development Board (TDB), under the Centre's Department of Science and Technology (DST), on Friday announced financial support for the development of India's first indigenous thrombectomy device for stroke care. A thrombectomy device is a specialised medical tool used to remove blood clots—also called thrombi—from blood vessels, particularly in the brain, to treat ischaemic strokes. Under the support programme, the TDB will sanction financial assistance to Mysuru-based S3V Vascular Technologies for the establishment of a state-of-the-art upstream integrated manufacturing facility at the Medical Devices Park, Oragadam, in Chennai's Sriperumbudur. Commenting on the development, TDB Secretary Rajesh Kumar Pathak said the project reflects the continued commitment to making India a global hub for affordable, high-end medical technology, especially in areas of critical public health need like stroke care. According to a study recently published in The Lancet Neurology journal, India registered over 1.25 million new stroke cases in 2021, a 51 per cent increase compared to 650,000 cases in 1990. Dr N G Vijaya Gopal, Managing Director of S3V Vascular Technologies, said the company's integrated manufacturing facility will not only reduce dependency on imports of the finished medical devices used in mechanical thrombectomy but also reduce India's reliance on the import of raw materials required for the manufacturing of these complex, life-saving devices. The company stated that it aims to integrate these devices into government reimbursement programmes such as Ayushman Bharat, thereby unlocking a domestic market estimated at $2 billion. 'As part of its outreach, S3V also plans to collaborate with leading hospitals to offer simulator-based training for young interventionalists—especially in Tier-II cities, where the stroke burden is high,' it said. Gopal added that S3V has initiated the CE and USFDA approval process for these devices to expand access to cutting-edge stroke care solutions across India, Asia, Latin America, Europe, and the United States. The company also intends to file patents for critical innovations such as the clot retriever head design, braid-over-coil aspiration catheter structures, and several advanced process technologies.
Hans India
30-05-2025
- Health
- Hans India
Govt to aid development of India's 1st indigenous thrombectomy device for stroke care
New Delhi: In a significant boost to India's medtech innovation landscape, the Technology Development Board (TDB), under the Union Department of Science and Technology (DST), on Friday announced financial support to the development of India's first indigenous thrombectomy device for stroke care. The board sanctioned assistance to Mysuru-based S3V Vascular Technologies' pioneering neuro-intervention integrated manufacturing plant for the treatment of stroke, which sees nearly 1.5 million cases every year in the country. The project envisions the establishment of a state-of-the-art upstream integrated manufacturing facility at the Medical Devices Park, Oragadam in Chennai's Sriperumbudur. The plant will develop and manufacture advanced mechanical thrombectomy kits -- a life-saving intervention for patients suffering from acute ischemic stroke due to large vessel occlusion. Compared to conventional thrombolysis, thrombectomy offers significantly improved outcomes, reducing the risk of long-term paralysis and disability. "The TDB is proud to support S3V's vision of building India's first comprehensive neuro-intervention manufacturing ecosystem. This project reflects our continued commitment to making India a global hub for affordable, high-end medical technology -- especially in areas of critical public health needs like stroke care," TDB Secretary Rajesh Kumar Pathak said. "The company's focus on integrating these devices into Ayushman Bharat further aligns with the national goal of inclusive healthcare access," he added. The initiative will help replace expensive imported devices with high-quality, locally manufactured alternatives, enhancing both the affordability and accessibility of stroke care in India. "Our integrated manufacturing facility will not only reduce dependency on imports of the finished medical devices used in Mechanical Thrombectomy but also reduces India's dependency on import of the raw materials used in manufacturing of these critical complex lifesaving medical devices," S3V Vascular Technologies Managing Director, Dr N.G. Vijaya Gopal, said, while lauding the government for its support. Gopal said the company has already initiated the CE and the US FDA approval process for the devices to expand access to cutting-edge stroke care solutions across India, Asia, Latin America, Europe, and the US.
